US5041107A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Electrically controllable, non-occluding, body implantable drug delivery system
Assignee: Cardiac Pacemakers Inc
•
Filing: 1989-10-06
•
Granted: 1991-08-20
•
Expires: 2009-10-06
Abstract
Abstract An implantable apparatus for continuous or periodic introduction of a drug to a desired release point in the body comprises an implantable power source and an elongated flexible plastic tubular catheter having a lumen filled with the drug to be delivered and containing therein a first device electrode. The distal end of the catheter is closed and located near the distal end is a port which extends through the wall of the catheter to communicate with the lumen. Just proximal of the port is a surface electrode mounted on the exterior wall of the catheter body. Extending through the catheter and joined to the drive electrode and the surface electrode are conductors which couple those electrodes to the implanted power source. Energization of the electrodes with a predetermined direct current potential causes a flow of the ionized drug molecules out through the port and into the area surrounding the surface electrode.
Inventors
- 👤 Ronald W. Heil, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 06:46
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/20; A61N1/30; A61N1/303; A61N1/306
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
151 words
An implantable drug delivery apparatus for long-term implantation within the body of an animal comprising: p1 (a) an implantable source of direct current potential; (b) an elongated, flexible plastic tubular catheter body having a proximal end, a distal end and at least one lumen extending from said proximal end to said distal end, and lumens at said distal end being closed, except for a port extending through said catheter body near said distal end; (c) first and second electrode means adapted to be connected to said source of direct current potential, said first electrode being contained within said lumen and said second electrode being a ring disposed on the exterior surface of said catheter body; and (d) A liquid solution containing a drug in solution substantially filling said sumen and engulfing said first electrode, the connection of said first and second electrodes to said source driving said drug through said port.
Claim 2
Dependent Claim
151 words
An implantable drug delivery apparatus for long-term implantation within the body of an animal comprising: p1 (a) an implantable source of direct current potential; (b) an elongated, flexible plastic tubular catheter body having a proximal end, a distal end and at least one lumen extending from said proximal end to said distal end, and lumens at said distal end being closed, except for a port extending through said catheter body near said distal end; (c) first and second electrode means adapted to be connected to said source of direct current potential, said first electrode being contained within said lumen and said second electrode being a ring disposed on the exterior surface of said catheter body; and (d) A liquid solution containing a drug in solution substantially filling said sumen and engulfing said first electrode, the connection of said first and second electrodes to said source driving said drug through said port.
Claim 3
Dependent Claim
13 words
The apparatus as in claim 1 wherein said port comprises an elongated slit.
Claim 4
Dependent Claim
15 words
The apparatus as in claim 1 wherein said ring is located proximally of said port.
Claim 5
Dependent Claim
30 words
The apparatus as in claim 1 wherein said port is of a size to prevent blood or tissue intrusion into said lumen and yet permit the outflow of said solution.
Claim 6
Dependent Claim
14 words
The apparatus as in claim 4 wherein said port is an elongated narrow slit.
Claim 7
Dependent Claim
24 words
The apparatus as in claim 1 and further including a membrane having a predetermined molecular weight cut-off mounted in covering relation to said port.
Claim 8
Dependent Claim
27 words
The apparatus as in claim 6 wherein said molecular weight cut-off is such that blood and tissue is incapable of penetrating through said membrane into said port.
Claim 9
Dependent Claim
30 words
The apparatus as in claim 7 wherein said membrane is a barrier to the flow of said solution but penetrable by said drug when driven by first and second electrodes.
Claim 10
Dependent Claim
30 words
The apparatus as in claim 1 and further including said drug in crystalline form to maintain a saturated condition in said solution upon delivery of said drug through said port.
Claim 11
Dependent Claim
13 words
The apparatus as in claim 1 wherein said solution is a gel material.
Claim 12
Dependent Claim
17 words
The apparatus as in claim 10 wherein said first electrode is in contact with said gel material.
References Cited (Backward Citations)
US3731681A
Cited
US3896806A
Cited
US3894538A
Cited
US3923060A
Cited
US3923426A
Cited
US3951147A
Cited
US4014334A
Cited
US4140121A
Cited
US4373527A
Cited
US4373527B1
Cited
US4639244A
Cited
US4744787A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-08-19 | 1995-02-18 | 1995-08-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-08-19 | 1999-02-18 | 1999-08-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-08-19 | 2003-02-18 | 2003-08-20 | $7700.00 | Window Closed / Lapsed |